117 related articles for article (PubMed ID: 3111130)
1. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
Albus C; Männchen E
Zentralbl Gynakol; 1987; 109(8):521-6. PubMed ID: 3111130
[TBL] [Abstract][Full Text] [Related]
2. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
Vesper VB; Feustel S
Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
5. [What does the micropill bring?].
Mall-Haefeli M
Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
[No Abstract] [Full Text] [Related]
6. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
Spellacy WN; Birk SA; Buggie J; Buhi WC
J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
[TBL] [Abstract][Full Text] [Related]
7. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
Petersen KR; Skouby SO; Dreisler A; Kühl C
Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral contraceptives on carbohydrate metabolism.
Wynn V; Godsland I
J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic study of blood in women who had used oral contraceptives.
Fridrichová I
Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
[TBL] [Abstract][Full Text] [Related]
10. [Oral contraceptive agents and antithrombin III].
Kamenov V; Nalbanski B
Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.
Luyckx AS; Gaspard UJ; Romus MA; Grigorescu F; De Meyts P; Lefèbvre PJ
Fertil Steril; 1986 May; 45(5):635-42. PubMed ID: 2938985
[TBL] [Abstract][Full Text] [Related]
12. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
13. A new ultra-low-dose combination oral contraceptive.
Woutersz TB
J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)].
Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U
Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282
[TBL] [Abstract][Full Text] [Related]
15. Norgestimate: overview of a monophasic formulation.
Anderson FD; Gillmer MD
Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():126-32. PubMed ID: 8260971
[No Abstract] [Full Text] [Related]
16. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
[TBL] [Abstract][Full Text] [Related]
17. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
Milchev N; Terzhumanov R; Grozdanov G; Krumov G
Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
[No Abstract] [Full Text] [Related]
18. Oral contraception, 1986. Focus on Triphasil.
Ellsworth H
J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
[TBL] [Abstract][Full Text] [Related]
19. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
20. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
Moggia AV
J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
